A clinical trial to study the effect of unani drugs in patients with gallstones.

A SINGLE BLIND CLINICAL TRIAL TO EVALUATE THE EFFICACY OF UNANI FORMULATION IN HISAT-UL-MARARA(CHOLELITHIASIS).

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/049499

Enrollment

Registered

2023-02-07

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Unani drugs: Each patient is treated with unani formulation with total duration of 90 days which is in form of 1. A decoction of Dolichos biflorus(7gms) twice daily 2. Powder of 5

Eligibility

Inclusion criteria

Inclusion criteria: 1.Symptomatic and asymptomatic cases of cholelithiasis 2. Stone of all sizes 3. Patient willing to be part of the study

Exclusion criteria

Exclusion criteria: 1. Patient less than 20 years and more than 65 years 2. Pancreatitis 3. Malignancy(Gallbladder, Hepatobiliary tract) 3. CBD Calculi 4. Patient not willing to be part of the study

Design outcomes

Primary

Measure	Time frame
Reduction in size of the Gallbladder stoneTimepoint: Once in 2 weeks	—

Secondary

Measure	Time frame
To relieve abdominal pain, nausea, vomiting, dyspepsia, flatulenceTimepoint: Once in 2 weeks	—

Countries

India

Contacts

Public ContactDrSyeda Sameen

Govt.Nizamia Tibbi College and General Hospital

drsakhussaini@gmail.com9704888561

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026